Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
9 Cards in this Set
- Front
- Back
1. Name the insulins that eliminated the problem of allergic reactions.
|
• Insulin discovered 80 years ago from extract of pancreas of the dog
• Best and Banting, Un Toronto • Early insulin preps from porcine and bovine sources had impurities to cause allergic reactions • Up to 1980’s, insulin sources were porcine and bovine – induced allergic reactions • In early 1980’s purified pork insulin and recombinant human insulin eliminated the allergy problem. |
|
2. Describe the chemical structure of insulin
|
• A polypeptide with molecular weight of approx 5600 Daltons
• Stimulates anabolic processes in muscle, liver and fat cells • Binds to cell-surface receptor to initiate signal propagation within the cell |
|
3. List the four regular insulin preparations and their onset and duration times.
|
See Notes
|
|
4. How does the human type insulin differ from the purified pork insulin?
|
• Humulin (human insulin)
o recombinant DNA origin o produced by Eli Lilly and Company o identical to insulin produced by human pancreas o contains no animal source pancreatic impurities that may contribute to allergic reactions |
|
5. List the limitations of the four standard insulins.
|
• After injection, they all caused in some fashion hypoglycemia because they worked very efficiently upon onset
• As glycosylated hemoglobin values approached normal range, “they just kept working” to further reduce blood sugar. • A “split-mix” regimen of NPH and regular insulin (70/30 mix respectively) used to this day was the best approach to provide both initial (after meals) and basal blood sugar control • Diabetes experts suggested that insulin formulation had to more closely duplicate the basal and mealtime components of endogenous insulin secretion. |
|
6. For the insulin analogues lispro, aspart and glargine, describe the chemical differences to endogenous insulin.
|
• Lispro
o Made from the inversion of the lysine of B29 and the proline of B28 of human insulin o Results in a very rapid action upon injection the most closely resembles prandial insulin release o Similar to insulin aspart in onset and duration of action o Structure not available at time of this program o Results in a very rapid action upon injection the most closely resembles prandial insulin release • Aspart o Proline at B28 replaced with the negatively charged aspartic acid o Results in a very rapid action upon injection the most closely resembles prandial insulin release • Glargine (long acting analog; brand name Lantus) o A prolonged absorption after sc injection with no peak activity o Produced by the substitution of glycine for asparagine at position A21 and the addition of two argine molecules at B30. |
|
7. Describe how the insulin analogues are used in diabetes.
|
• Insulin analogue preps
o Had action profiles that afforded more flexible treatment regimens o Had lower risk of developing hypoglycemia • Used: o Individually in type 1 diabetes better mimic endogenous insulin o Together with oral drugs in type 2 diabetes i.e. Insulin lispro at mealtime enhances actions of the orals |
|
8. Define the preparation known as Novolog Mix 70/30 and its duration of action.
|
• Premixed insulin analogues
o Brand name= Novolog Mix 70/30 Insulin aspart protamine 70% Insulin aspart 30% A single injection with rapid onset like regular insulin, and then a duration similar to intermediate-acting insulins (12-18 hrs) |
|
9. For insulin detemir and insulin glulisine, define what they are chemically, their durations of action and how used in diabetes.
|
• Insulin detemir
o A single amino acid omission (threonine at B 30) and addition of a 14 carbon fatty acid chain at B29 o Lower dose = 12-18 hours duration o Higher dose = 24 hour duration o Treatment of both type 1 diabetes and type 2 diabetes to improve glycemic control • Insulin glulisine (Apidra) o Replacement of two amino acids on the B chain (B3, B29) o A rapid acting insulin analog (2-4 hours) o Treatment of both type 1 diabetes and type 2 diabetes to improve glycemic control |